The Impact of Brexit on the NHS: Panel Discussion  

In our exclusive podcast, you can hear from a panel of experts from King’s College London who discuss the repercussions that Britain’s departure from the EU will have on the NHS.

Recorded at Strand Campus on 29 March, the panel tackled questions around:

  • How the UK will recruit nurses, doctors and researchers
  • How clinical and medical trials will be regulated
  • How research will be funded

Interested in hearing what was discussed? You can listen to the podcast here


Professor Jonathan Grant, Vice-President/Vice-Principal (Service) at King’s College London and Professor of Public Policy in the Policy Institute at King’s. Jonathan’s main research interests are in biomedical and health Research & Development policy, research impact assessment and the use of research and evidence in policy and decision making. Jonathan co-founded the International School on Research Impact Assessment. Jonathan received his PhD from the Faculty of Medicine, University of London (King’s College London) and his B.Sc. (Econ) from the London School of Economics.


Sir Robert Lechler, Vice-Principal (Health) and Executive Director of King’s Health Partners Academic Health Sciences Centre. Robert became Dean of King’s College School of Medicine in 2004. The following year he succeeded Professor Sir Graeme Catto as Vice-Principal (Health) in charge of the five Health Schools of King’s. Robert was also Deputy Chair of Guy’s and St Thomas’ NHS Foundation Trust from 2004-2009. He was appointed as Executive Director of King’s Health Partners in June 2009.

Baroness Sally Morgan, Vice-Chair of the College Council, member of the Council's Estates Strategy Committee and the Fellowships and Honorary Degrees Committee and Trust Board Chair (non-executive) at Royal Brompton & Harefield. She was made a life peer in 2001. She is a member of the House of Lords Science & Technology Committee.

Professor Tim Irish, Professor of Practice at King’s Business School. Professor Irish has also been a non-executive director of NICE since April 2015. He has worked for 30 years in the healthcare industry, both in the UK and internationally.